Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 53.32B 7.9B 6.87B 6.39B 5.87B 11.1B 754B 11.26B 75.33B 29.59B 376B 29.69B 29.03B 1,244B | P/E 2026 * |
39.2x | P/E 2027 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.27B 7.16B 6.22B 5.79B 5.32B 10.05B 683B 10.19B 68.19B 26.78B 340B 26.87B 26.28B 1,126B | EV / Sales 2026 * |
5.97x | EV / Sales 2027 * | 5.04x |
| Free-Float |
61.14% | Yield 2026 * |
0.96% | Yield 2027 * | 1.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.54B | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -0.75% | +4.83% | +27.98% | +48.89% | 401.41B | |
| Weighted average by Cap. | -0.24% | +4.87% | +36.61% | +70.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.08B 1.2B 1.04B 969M 890M 1.68B 114B 1.71B 11.42B 4.48B 57B 4.5B 4.4B 189B | 9.7B 1.44B 1.25B 1.16B 1.07B 2.02B 137B 2.05B 13.71B 5.38B 68.44B 5.4B 5.28B 226B |
| Net income | 1.4B 208M 181M 168M 154M 292M 19.83B 296M 1.98B 778M 9.89B 781M 763M 32.72B | 1.77B 262M 228M 212M 195M 368M 25B 373M 2.5B 981M 12.47B 984M 963M 41.26B |
| Net Debt | -5.05B -749M -650M -605M -556M -1.05B -71.4B -1.07B -7.13B -2.8B -35.62B -2.81B -2.75B -118B | -4.39B -651M -566M -526M -484M -914M -62.11B -928M -6.21B -2.44B -30.98B -2.45B -2.39B -102B |
| Date | Price | Change |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
